Vargas MS, Estrada RC

Language: Spanish
References: 11
Page: 227-231
PDF size: 169.20 Kb.

ABSTRACT

The intrauterine device is a safe, effective, long-lasting, yet reversible method of contraception. This method should be consider in general population including, nulliparous, adolescent women in immediate postpartum and post abortion. In addition to its high effectiveness this method provides and alternative in patients with chronic diseases or in need of emergency contraception.

REFERENCES

1. Allen.R.(2009); Expanding access to intrauterine contraception; American Journal of Obstetrics and gynecology; 201:456 e 1-5

2. Armstrong. C. (2007); ACOG Releases Guidelines on Hormonal Contraceptives in Women with Coexisting Medical Conditions; America family Physician; 75: 1253–1258.

3. Blumenthal, Voedisch.A(2010); Strategies to prevent unintended pregnancy increasing use of longacting reversible contraception; Human reproductive update;17:121-131

4. Cullwell. K and colls(2009)Medical eligibility criteria for contraceptive use, World health organization ; 79-81

5. Espey.E, Ogburn.T,Foteo.D (2008) Contraception: What Every Internist Should Know; The Medical Clinics of NorthAmerica;92:1037–1058

6. Linares. A, Schutt-Aine.A(2011); Contraception, Textbook of family medicine, 469-476

7. Lyus, R and colls (2009); Use of Mirena LNGIUS and Pargard CuT380A intrauterine devices in nulliparous women, 1-5

8. MacIsaac. L, Espey. E (2007);Intrauterine contraception the pendulum: swings back; Obstetrics and gynecology Clinics of North America; 34: 91-111

9. Mestad. R and colls(2011); Reversible contraception update: The importance of long- acting reversible contraception; Postgrad Med; 121(4): 18-25

10. Randell. A(2011), Guidelines for the use of Long acting reversible contraception, American family Physician; 85(4) 403-404

11. Teal. S(2007) Contraception for women with chronic medical conditions; Obstetrics and gynecology clinics; 34: 113-126